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doi:10.1016/j.ejvsextra.2011.01.003Abstract Self-expandable nitinol stents are designed to provide optimal vessel patency in
cases of stenosis or occlusion in peripheral arteries and veins. There are few numbered re-
ported cases of the use of nitinol stents in inferior vena cava (IVC) stenoses. We report the
successful placement of a nitinol stent within the IVC in a patient with a benign stenosis that
developed due to retroperitoneal fibrosis (RF).
ª 2011 European Society for Vascular Surgery. Published by Elsevier Ltd.
Open access under CC BY-NC-ND license.Introduction
Retroperitoneal fibrosis or Ormond’s disease (RF) is
considered a rare disease of unknown aetiology.1 Patho-
logically, the idiopathic form is characterised by the
retroperitoneal development of fibrous tissue and inflam-
matory cells that may cause obstruction of the ureters and
the great vessels.1 A case report of a female patient with RF
is presented herein, in whom an inferior vena cava (IVC)
stenosis was successfully resolved intravascularly.jvs.2011.01.026.
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A 70-year-old female patient presented with abdominal
pain and significant bilateral leg oedema (Fig. 1(a)) and was
referred for decompression of an IVC stenosis. A previous
multidetector row computed tomography (MDCT) exami-
nation showed the probable cause of compression to be
a retroperitoneal soft tissue mass that encased the great
vessels (Fig. 1(b)) and was pathologically proven to be RF
with a CT-guided biopsy. Under ultrasound guidance, a 7-Fr
sheath was inserted from the right femoral vein into the
IVC, and venography demonstrated the severe stenosis
(Fig. 1(c)). To treat the caval stenosis, a 100-mm-long, 16-
mm-wide self-expandable nitinol stent (Bard, LUMINEXX)
was implanted into the infrarenal caval vein (Fig. 1(d)),
after balloon dilatation had failed to open the stenosis
sufficiently. Successful stent deployment was followed by
balloon angioplasty to achieve maximum stent diameterElsevier Ltd. Open access under CC BY-NC-ND license.
Figure 1 (a) Photograph of the patient presenting with lower limb oedema. (b)The axial contrast enhanced MDCT image shows
retroperitoneal fibrosis (thick arrow) encasing the IVC (open arrow). (c) Phlebography shows severe IVC stenosis (arrow). (d)
Succesful stent deployment [note the high-grade stenosis (arrow) causing stent deformation]. (e) Additional balloon angioplasty to
achieve nominal stent diameter.
e22 E. Perdikakis et al.(Fig. 1(e)). Leg oedema subsided within 48 h after stenting
(Fig. 2(a)) and the patient was put on warfarin for long-
term anticoagulation and treated by corticosteroids for
retroperitoneal fibrosis. A follow-up MDCT exam 6 weeks
later showed patency, further stent deployment and
regression of the disease (Fig. 2(b)). The patient remains
asymptomatic 1 year post treatment.Discussion
In the idiopathic form of RF, an auto-immune mechanism is
postulated to be the underlying cause and corticosteroids
are primarily used as a first-line treatment option.1 TheFigure 2 (a) Photograph of the patient 2 days post stenting show
weeks post stenting reveals IVC patency (arrow) and RF regressionusual therapeutic scheme is an initial dose of prednisone at
40e60 mg day1 with gradual tapering to 10 mg day1
within 2e3 months, which is progressively discontinued
after 1e2 years. Azathioprine, cyclophosphamide, metho-
trexate, cyclosporin and mycophenolate mofetil have also
been used alone or in association with steroids.1 Tamox-
ifen, a selective oestrogen receptor modulator, has also
been used recently as a therapeutic option.1 The afore-
mentioned medical treatment inhibits the progression of
the disease and relieves the obstructive complications.
Although surgery can be performed to overcome venous
complications, many investigators advocate the use of
endovascular treatment nowadays.1e4 Stents are used as
first-line therapeutic treatment in nearly all venouss subsiding of leg oedema. (b) The MDCT scan (venous phase) 6
. Compare with figure 1.
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relief of symptoms and accelerates clinical improvement.
Even though metal stents are preferred for endovascular
treatment of large veins, we selected a self-expandable
nitinol stent. Themain advantages of a self-expandable stent
are its flexibility, its tendency to maintain the length
constant albeit it lacks in radial force compared to metal
stents and its ability to self-expand thermoelastically to its
nominal diameter at body temperature.2e4 To the best of our
knowledge, this is the first report of the use of a self-
expandable nitinol stent as an alternative to metal stents in
cases of RF caval stenoses, with midterm follow-up MDCT
imaging and l year clinical follow-up.
Regardless of the good outcome in our case, two issues
need to be further elucidated. First, the stent itself may act
as a possible adjunctive source of inflammatory reaction,
requiring thus a more aggressive and prolonged anti-
coagulation and steroid treatment. The term ‘chronic peri-
aortitis’ is being used in similar cases and a potentially
immune-mediated pathogenesis is postulated.4 A foreign-
body reaction might be implicated in the progression or the
de novo development of periaortic fibrosis after endovas-
cular procedures, as van Bommel et al. and Simons et al.
reported in their studies.5,6 The second issue that needs
clarification is the decision for stenting in our case. In
retrospect, the patient’s symptoms could have resolved by
immunosuppressive treatment alone. To argue that no
surgical or medical treatment for RF has been widely tested
in controlled trials.1 Furthermore, many authors advocate
the use of surgery or stenting in cases of moderate or severe
organ compromise.1,4e6 In our case, the high-grade IVC
stenosis, the risk for total occlusionethrombosis and the
clinical picture influenced our final therapeutic decision.
In conclusion, a rare case of an IVC stenosis that was
treated with a self-expandable nitinol stent is presentedherein. Nevertheless, larger patient cohort studies are
needed to investigate the feasibility and safety with a long-
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